Understanding the double-edge sword of steroids

Glucocorticoids are a type of steroid hormone that are used to treat everything from asthma to arthritis, but the impact of these powerful anti-inflammatory drugs – particularly in prolonged, low-doses – remains to be fully understood.

Now researchers from Flinders University are on a mission to find out how long-term steroid treatment for and pituitary tumours affect the body’s metabolic and cardiovascular mechanisms.

Between half and one per cent of the country’s population take steroids, or about 1000 people in South Australia, with the over 50s the most common consumer.

“Research has already proven that high doses of steroids can cause diabetes, heart disease and weight gain but most patients are treated with low doses over a long period of time,” chief investigator Dr. Morton Burt (pictured), a senior lecturer in the School of Medicine, said.

“Yet there’s less evidence on the effects of low-dose steroid therapy,” he said.

“So what we want to know is whether steroids mainly reduce insulin production or make the body resistant to insulin.

“Without sufficient insulin the body can’t reduce glucose – and too much glucose in the blood causes diabetes.”

Dr. Burt’s preliminary studies have shown that therapeutic doses of steroids only increase blood glucose after eating. After eating most glucose is taken up into muscle. This suggests steroids may predominantly cause insulin resistance in muscle.

So far Dr. Burt has performed detailed metabolic studies on about a dozen people before and one week after commencing steroid treatment and has also studied a similar number who have been taking steroids for a long period of time.

“We give patients an injection of insulin to measure how much insulin they secrete over a 60 minute period,” Dr. Burt said.

“Subjects also have a six hour infusion of insulin and glucose to measure how resistant they are to and whether the resistance is in the liver or muscle or both.”

In another study, Dr. Burt is studying patients with pituitary tumours to determine what impact a higher or lower dose of steroids has on their risk of heart disease.

“For most of us, our blood vessels become more relaxed after eating but our hypothesis is that this will not happen in people who are using steroid therapy.”

Dr Burt, an endocrinologist at Southern Adelaide Diabetes and Endocrine Services, said the aim of his research is to develop new treatments that reduce the risk of heart disease in people who have steroid-induced diabetes.

are crucial in the treatment of many chronic diseases, yet they also have harmful side-effects. So if we can better understand these effects it will pave the way for therapies that specifically reverse the major metabolic abnormalities they induce – and reduce cardiovascular risk.”

Dr. Burt is supported by a South Australian Health Practitioner Fellowship and recently won a Flinders University’s 2011 Vice-Chancellor’s Awards for Early Career Researchers.

He and Dr. Elke Sokoya, a senior lecturer in human physiology in the School of Medicine, each have won $39,770 in research funding in the latest Diabetes Australia Research Trust Awards.

Provided by Flinders University

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Could a drug reverse Type 2 diabetes?

Sep 23, 2011

Australian researchers have isolated a ‘master gene’ that controls Type 2 diabetes and say drugs that prevent or reverse the condition by switching off the gene may be as little as five years away

Researchers study biofeedback for asthma

Nov 22, 2011

National Jewish Health researchers are delving into the biology of biofeedback to understand how it helps asthma patients and what role it could play in reducing medication use for the chronic lung disease. In a study funded ...

Recommended for you

Growing a blood vessel in a week

14 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

17 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments